US Patent Number
The invention relates to methods and compositions for the treatment or prevention of ocular angiogenesis and neovascularization associated with neovascular disease. Administration of vascular endothelial growth factor (VEGF)-A into the eye when macrophage infiltration is reduced inhibits ocular angiogenesis.
University of Kentucky Research Foundation, Lexington, KY (US)
Ambati, Jayakrishna, "VEGF-A as an Inhibitor of Angiogenesis and Methods of Using Same" (2009). Ophthalmology and Visual Science Faculty Patents. 19.